Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study Josefina Cortés-Hernández; Carlos Marras Fernández-Cid; Jose Luis Andreu Sánchez; Jaime Calvo Alén; Angel M. García-Aparicio; Elvira Díez Álvarez; Francisco Javier Hidalgo Bermejo; Carlos Coronell; Alessandra Perna; Josep Ordi Ros;

Role of the anti-RO/SSA antibody in patients with systemic lupus erythematosus Paula Pérez Jiménez; Laura Tío Barrera; José Luis Andréu Sánchez; Tarek Carlos Salman-Monte; Irene Carrión-Barberà;

Epidemiology of systemic lupus erythematosus in Latin America Ivet Etchegaray-Morales; Claudia Mendoza-Pinto; Francisco Javier Arellano-Avendaño; Sandra Ibañez-Ovando; Pamela Munguía-Realpozo; Jacsiry Guadalupe Orbe-Sosa; Edith Ramírez-Lara; Mario García-Carrasco;